Drug-induced Takotsubo Cardiomyopathy

Heart Failure Clinics

Volumn 9, Issue 2, 2013, Pages 225-231

  Izumi, Yasukatsu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Drug induced; Iatrogenic; Inotropic agents; Stress cardiomyopathy; Takotsubo cardiomyopathy

Indexed keywords

ADRENALIN; ANAGRELIDE; ATROPINE; BETA ADRENERGIC RECEPTOR; CALCIUM; CATECHOLAMINE; COMBRETASTATIN; CYCLIC AMP; DOBUTAMINE; DULOXETINE; EPHEDRINE; ERGOMETRINE; FLUOROURACIL; LEVOTHYROXINE; METOPROLOL; NORTRIPTYLINE; OXYCODONE; OXYGEN RADICAL; OXYMETAZOLINE; PAZOPANIB; POTASSIUM CHLORIDE; VENLAFAXINE;

APOPTOSIS; DISEASE ACTIVITY; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG OVERDOSE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HUMAN; LEUKOCYTE MIGRATION; MUSCLE ATROPHY; NONHUMAN; OXIDATIVE STRESS; PARASYMPATHETIC FUNCTION; PATHOGENESIS; REVIEW; SYMPATHETIC TONE; T WAVE INVERSION; TAKOTSUBO CARDIOMYOPATHY; THORAX PAIN; THYROTOXICOSIS; VASOCONSTRICTION; VASOSPASM;

CATECHOLAMINES; HUMANS; SYMPATHOMIMETICS; TAKOTSUBO CARDIOMYOPATHY;

EID: 84876733300     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2012.12.004     Document Type: Review

References (44)

1. Bybee K.A., Prasad A. Stress-related cardiomyopathy syndromes. Circulation 2008, 118(4):397-409.
2. Kurowski V., Kaiser A., von Hof K., et al. Apical and midventricular transient left ventricular dysfunction syndrome (tako-tsubo cardiomyopathy): frequency, mechanisms, and prognosis. Chest 2007, 132(3):809-816.
3. Litvinov I.V., Kotowycz M.A., Wassmann S. Iatrogenic epinephrine-induced reverse Takotsubo cardiomyopathy: direct evidence supporting the role of catecholamines in the pathophysiology of the "broken heart syndrome". Clin Res Cardiol 2009, 98(7):457-462.
4. Prasad A., Madhavan M., Chareonthaitawee P. Cardiac sympathetic activity in stress-induced (Takotsubo) cardiomyopathy. Nat Rev Cardiol 2009, 6(6):430-434.
5. Izumi Y., Okatani H., Shiota M., et al. Effects of metoprolol on epinephrine-induced takotsubo-like left ventricular dysfunction in non-human primates. Hypertens Res 2009, 32(5):339-346.
6. Ueyama T., Kasamatsu K., Hano T., et al. Catecholamines and estrogen are involved in the pathogenesis of emotional stress-induced acute heart attack. Ann N Y Acad Sci 2008, 1148:479-485.
7. Amariles P. A comprehensive literature search: drugs as possible triggers of Takotsubo cardiomyopathy. Curr Clin Pharmacol 2011, 6(1):1-11.
8. Sealove B.A., Tiyyagura S., Fuster V. Takotsubo cardiomyopathy. J Gen Intern Med 2008, 23(11):1904-1908.
9. Kinugawa S., Post H., Kaminski P.M., et al. Coronary microvascular endothelial stunning after acute pressure overload in the conscious dog is caused by oxidant processes: the role of angiotensin II type 1 receptor and NAD(P)H oxidase. Circulation 2003, 108(23):2934-2940.
10. Lee J.C., Downing S.E. Ventricular function in norepinephrine-induced cardiomyopathic rabbits. Am J Physiol 1982, 242(2):H191-H196.
11. Movahed A., Reeves W.C., Mehta P.M., et al. Norepinephrine-induced left ventricular dysfunction in anesthetized and conscious, sedated dogs. Int J Cardiol 1994, 45(1):23-33.
12. Lyon A.R., Rees P.S., Prasad S., et al. Stress (Takotsubo) cardiomyopathy-a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat Clin Pract Cardiovasc Med 2008, 5(1):22-29.
13. Senba E., Ueyama T. Stress-induced expression of immediate early genes in the brain and peripheral organs of the rat. Neurosci Res 1997, 29(3):183-207.
14. Snoeckx L.H., Cornelussen R.N., Van Nieuwenhoven F.A., et al. Heat shock proteins and cardiovascular pathophysiology. Physiol Rev 2001, 81(4):1461-1497.
15. Ueyama T., Senba E., Kasamatsu K., et al. Molecular mechanism of emotional stress-induced and catecholamine-induced heart attack. J Cardiovasc Pharmacol 2003, 41(Suppl 1):S115-S118.
16. Ueyama T. Emotional stress-induced Tako-tsubo cardiomyopathy: animal model and molecular mechanism. Ann NY Acad Sci 2004, 1018:437-444.
17. Ito K., Sugihara H., Kawasaki T., et al. Assessment of ampulla (Takotsubo) cardiomyopathy with coronary angiography, two-dimensional echocardiography and 99mTc-tetrofosmin myocardial single photon emission computed tomography. Ann Nucl Med 2001, 15(4):351-355.
18. Cherian J., Kothari S., Angelis D., et al. Atypical takotsubo cardiomyopathy: dobutamine-precipitated apical ballooning with left ventricular outflow tract obstruction. Tex Heart Inst J 2008, 35(1):73-75.
19. Margey R., Diamond P., McCann H., et al. Dobutamine stress echo-induced apical ballooning (Takotsubo) syndrome. Eur J Echocardiogr 2009, 10(3):395-399.
20. Crimi E., Baggish A., Leffert L., et al. Images in cardiovascular medicine. Acute reversible stress-induced cardiomyopathy associated with cesarean delivery under spinal anesthesia. Circulation 2008, 117(23):3052-3053.
21. Littlejohn F.C., Syed O., Ornstein E., et al. Takotsubo cardiomyopathy associated with anesthesia: three case reports. Cases J 2008, 1(1):227.
22. Citro R., Pascotto M., Provenza G., et al. Transient left ventricular ballooning (tako-tsubo cardiomyopathy) soon after intravenous ergonovine injection following caesarean delivery. Int J Cardiol 2010, 138(2):e31-e34.
23. Keskin A., Winkler R., Mark B., et al. Tako-tsubo cardiomyopathy after administration of ergometrine following elective caesarean delivery: a case report. J Med Case Rep 2010, 4:280.
24. Forte R.Y., Precoma-Neto D., Chiminacio Neto N., et al. Myocardial infarction associated with the use of a dietary supplement rich in ephedrine in a young athlete. Arq Bras Cardiol 2006, 87(5):e179-e181.
25. Wang R., Souza N.F., Fortes J.A., et al. Apical ballooning syndrome secondary to nasal decongestant abuse. Arq Bras Cardiol 2009, 93(5):e75-e78.
26. Sandhu G., Servetnyk Z., Croitor S., et al. Atropine aggravates signs and symptoms of Takotsubo cardiomyopathy. Am J Emerg Med 2010, 28(2):258. e255-7.
27. De Roock S., Beauloye C., De Bauwer I., et al. Tako-tsubo syndrome following nortriptyline overdose. Clin Toxicol (Phila) 2008, 46(5):475-478.
28. Bergman B.R., Reynolds H.R., Skolnick A.H., et al. A case of apical ballooning cardiomyopathy associated with duloxetine. Ann Intern Med 2008, 149(3):218-219.
29. Christoph M., Ebner B., Stolte D., et al. Broken heart syndrome: tako Tsubo cardiomyopathy associated with an overdose of the serotonin-norepinephrine reuptake inhibitor Venlafaxine. Eur Neuropsychopharmacol 2010, 20(8):594-597.
30. Basselin C., Fontanges T., Descotes J., et al. 5-Fluorouracil-induced Tako-Tsubo-like syndrome. Pharmacotherapy 2011, 31(2):226.
31. Grunwald M.R., Howie L., Diaz L.A. Takotsubo cardiomyopathy and Fluorouracil: case report and review of the literature. J Clin Oncol 2012, 30(2):e11-e14.
32. Tsibiribi P., Bui-Xuan C., Bui-Xuan B., et al. Cardiac lesions induced by 5-fluorouracil in the rabbit. Hum Exp Toxicol 2006, 25(6):305-309.
33. Jensen S.A., Sorensen J.B. 5-fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity. Cancer Chemother Pharmacol 2012, 69(1):57-64.
34. Bhakta S., Flick S.M., Cooney M.M., et al. Myocardial stunning following combined modality combretastatin-based chemotherapy: two case reports and review of the literature. Clin Cardiol 2009, 32(12):E80-E84.
35. Dark G.G., Hill S.A., Prise V.E., et al. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature. Cancer Res 1997, 57(10):1829-1834.
36. Grosios K., Loadman P.M., Swaine D.J., et al. Combination chemotherapy with combretastatin A-4 phosphate and 5-fluorouracil in an experimental murine colon adenocarcinoma. Anticancer Res 2000, 20(1A):229-233.
37. White A.J., LaGerche A., Toner G.C., et al. Apical ballooning syndrome during treatment with a vascular endothelial growth factor receptor antagonist. Int J Cardiol 2009, 131(3):e92-e94.
38. Proietti R., Rognoni A., Ardizzone F., et al. Atypical Takotsubo syndrome during anagrelide therapy. J Cardiovasc Med (Hagerstown) 2009, 10(7):546-549.
39. Kwon S.A., Yang J.H., Kim M.K., et al. A case of Takotsubo cardiomyopathy in a patient with iatrogenic thyrotoxicosis. Int J Cardiol 2010, 145(3):e111-e113.
40. van de Donk N.W., America Y.G., Zelissen P.M., et al. Takotsubo cardiomyopathy following radioiodine therapy for toxic multinodular goitre. Neth J Med 2009, 67(10):350-352.
41. Parodi G., Antoniucci D. Transient left ventricular apical ballooning syndrome after inadvertent epidural administration of potassium chloride. Int J Cardiol 2008, 124(1):e14-e15.
42. Jefic D., Koul D., Boguszewski A., et al. Transient left ventricular apical ballooning syndrome caused by abrupt metoprolol withdrawal. Int J Cardiol 2008, 131(1):e35-e37.
43. Rivera J.M., Locketz A.J., Fritz K.D., et al. "Broken heart syndrome" after separation (from OxyContin). Mayo Clin Proc 2006, 81(6):825-828.
44. Arora S., Alfayoumi F., Srinivasan V. Transient left ventricular apical ballooning after cocaine use: is catecholamine cardiotoxicity the pathologic link?. Mayo Clin Proc 2006, 81(6):829-832.